Bayer drops challenge over patent extension for contraceptive drug

Article 2022-05-09 1:13 pm By Cat Fredenburgh | Melbourne

Please login to bookmark

Bayer has dropped its appeal to a ruling that quashed an extension for its patent covering an oral contraceptive, after the Full Court dealt drug makers a blow in two separate cases on how patent term extensions should be calculated.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au